Devices
Monitoring
FDA
News Release - December 30, 2009
ZOLL Receives FDA Clearance to Market E Series Defibrillators with Carbon Monoxide Monitoring
Source: ZOLL Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.